Latest

OncoResponse Mines PD-1 Therapy “Elite Responders” For IO Breakthroughs

FDA Authorizes Merck’s Covid-19 Pill for At-Home Treatment

Coherus Announces U.S. FDA Approval of YUSIMRY™ (adalimumab-aqvh)

Behind a New Pill to Treat Covid: A Husband-and-Wife Team and a Hunch

Coherus and Junshi Biosciences Announce Positive Interim Overall Survival Results of CHOICE-01, a Phase 3 Clinical Trial Evaluatin

Merck’s Covid-19 Drug Is a Boon for Wall Street and Main Street

Coherus and Junshi announces positive interim data for pivotal trial in esophageal cancer

CalciMedica Reports Topline Data from the Auxora CARDEA Phase 2 COVID-19 Pneumonia Clinical Trial